Abstract
Periportal and perivenous hepatocytes show zonal heterogeneity in metabolism and signaling. Here, hepatic zonation in mouse liver was analyzed by non-targeted mass spectrometry (MS) and by the antibody-based DigiWest technique, yielding a comprehensive overview of protein expression in periportal and perivenous hepatocytes. Targeted immunoaffinity-based proteomics were used to substantiate findings related to drug metabolism. 165 (MS) and 82 (DigiWest) zonated proteins were identified based on the selected criteria for statistical significance, including 7 (MS) and 43 (DigiWest) proteins not identified as zonated before. New zonated proteins especially comprised kinases and phosphatases related to growth factor-dependent signaling, with mainly periportal localization. Moreover, the mainly perivenous zonation of a large panel of cytochrome P450 enzymes was characterized. DigiWest data were shown to complement the MS results, substantially improving possibilities to bioinformatically identify zonated biological processes. Data mining revealed key regulators and pathways preferentially active in either periportal or perivenous hepatocytes, with β-catenin signaling and nuclear xeno-sensing receptors as the most prominent perivenous regulators, and several kinase- and G-protein-dependent signaling cascades active mainly in periportal hepatocytes. In summary, the present data substantially broaden our knowledge of hepatic zonation in mouse liver at the protein level.
Acknowledgments
The authors acknowledge expert technical assistance by Silvia Vetter.
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: None declared.
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
References
Ben-Moshe, S., Shapira, Y., Moor, A.E., Manco, R., Veg, T., Halpern, K.B., and Itzkovitz, S. (2019). Spatial sorting enables comprehensive characterization of liver zonation. Nat. Metab. 1: 899–911, https://doi.org/10.1038/s42255-019-0109-9.Search in Google Scholar PubMed PubMed Central
Benhamouche, S., Decaens, T., Perret, C., and Colnot, S. (2006). Wnt/β-catenin pathway and liver metabolic zonation: a new player for an old concept. Med. Sci. 22: 904–906, https://doi.org/10.1051/medsci/20062211904.Search in Google Scholar PubMed
Berndt, N., Kolbe, E., Gajowski, R., Eckstein, J., Ott, F., Meierhofer, D., Holzhütter, H.G., and Matz-Soja, M. (2020). Functional consequences of metabolic zonation in murine livers: new insights for an old story. Hepatology 73: 795–810, https://doi.org/10.1002/hep.31274.Search in Google Scholar PubMed
Botini, F.F., Suzuki-Kemmelmeier, F., Nascimento, E.A., Ide, L.T., and Bracht, A. (2005). Zonation of alanine metabolism in the bivascularly perfused rat liver. Liver Int. 25: 861–871, https://doi.org/10.1111/j.1478-3231.2005.01093.x.Search in Google Scholar PubMed
Braeuning, A. (2009). Regulation of cytochrome P450 expression by Ras- and beta-catenin-dependent signaling. Curr. Drug Metabol. 10: 138–158, https://doi.org/10.2174/138920009787522160.Search in Google Scholar PubMed
Braeuning, A., Ittrich, C., Kohle, C., Buchmann, A., and Schwarz, M. (2007). Zonal gene expression in mouse liver resembles expression patterns of Ha-ras and beta-catenin mutated hepatomas. Drug Metabol. Dispos. 35: 503–507, https://doi.org/10.1124/dmd.106.013656.Search in Google Scholar PubMed
Braeuning, A., Ittrich, C., Kohle, C., Hailfinger, S., Bonin, M., Buchmann, A., and Schwarz, M. (2006). Differential gene expression in periportal and perivenous mouse hepatocytes. FEBS J. 273: 5051–5061, https://doi.org/10.1111/j.1742-4658.2006.05503.x.Search in Google Scholar PubMed
Braeuning, A., Kohle, C., Buchmann, A., and Schwarz, M. (2011). Coordinate regulation of cytochrome P450 1a1 expression in mouse liver by the aryl hydrocarbon receptor and the β-catenin pathway. Toxicol. Sci. 122: 16–25, https://doi.org/10.1093/toxsci/kfr080.Search in Google Scholar PubMed
Braeuning, A., Sanna, R., Huelsken, J., and Schwarz, M. (2009). Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1. Drug Metabol. Dispos. 37: 1138–1145, https://doi.org/10.1124/dmd.108.026179.Search in Google Scholar PubMed
Braeuning, A. and Schwarz, M. (2010). β-Catenin as a multilayer modulator of zonal cytochrome P450 expression in mouse liver. Biol. Chem. 391: 139–148, https://doi.org/10.1515/BC.2010.012.Search in Google Scholar
Chesire, D.R., Dunn, T.A., Ewing, C.M., Luo, J., and Isaacs, W.B. (2004). Identification of aryl hydrocarbon receptor as a putative Wnt/β-catenin pathway target gene in prostate cancer cells. Canc. Res. 64: 2523–2533, https://doi.org/10.1158/0008-5472.can-03-3309.Search in Google Scholar PubMed
Forootan, S.S., Mutter, F.E., Kipar, A., Iwawaki, T., Francis, B., Goldring, C.E., Park, B.K., and Copple, I.M. (2017). Real-time in vivo imaging reveals localised Nrf2 stress responses associated with direct and metabolism-dependent drug toxicity. Sci. Rep. 7: 16084, https://doi.org/10.1038/s41598-017-16491-2.Search in Google Scholar PubMed PubMed Central
Gebhardt, R. (1992). Metabolic zonation of the liver: regulation and implications for liver function. Pharmacol. Ther. 53: 275–354, https://doi.org/10.1016/0163-7258(92)90055-5.Search in Google Scholar PubMed
Gougelet, A., Torre, C., Veber, P., Sartor, C., Bachelot, L., Denechaud, P.D., Godard, C., Moldes, M., Burnol, A.F., Dubuquoy, C., et al.. (2014). T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice. Hepatology 59: 2344–2357, https://doi.org/10.1002/hep.26924.Search in Google Scholar PubMed
Groothuis, G.M. and Meijer, D.K. (1992). Hepatocyte heterogeneity in bile formation and hepatobiliary transport of drugs. Enzyme 46: 94–138, https://doi.org/10.1159/000468780.Search in Google Scholar PubMed
Hailfinger, S., Jaworski, M., Braeuning, A., Buchmann, A., and Schwarz, M. (2006). Zonal gene expression in murine liver: lessons from tumors. Hepatology 43: 407–414, https://doi.org/10.1002/hep.21082.Search in Google Scholar PubMed
Halpern, K.B., Shenhav, R., Matcovitch-Natan, O., Toth, B., Lemze, D., Golan, M., Massasa, E.E., Baydatch, S., Landen, S., Moor, A.E., et al.. (2017). Single-cell spatial reconstruction reveals global division of labour in the mammalian liver. Nature 542: 352–356, https://doi.org/10.1038/nature21065.Search in Google Scholar PubMed PubMed Central
Honkakoski, P. and Negishi, M. (2000). Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J. 347: 321–337, https://doi.org/10.1042/0264-6021:3470321.10.1042/bj3470321Search in Google Scholar
Jungermann, K. (1995). Zonation of metabolism and gene expression in liver. Histochem. Cell Biol. 103: 81–91, https://doi.org/10.1007/bf01454004.Search in Google Scholar PubMed
Jungermann, K. and Kietzmann, T. (1997). Role of oxygen in the zonation of carbohydrate metabolism and gene expression in liver. Kidney Int. 51: 402–412, https://doi.org/10.1038/ki.1997.53.Search in Google Scholar PubMed
Jungermann, K. and Thurman, R.G. (1992). Hepatocyte heterogeneity in the metabolism of carbohydrates. Enzyme 46: 33–58, https://doi.org/10.1159/000468777.Search in Google Scholar PubMed
Kietzmann, T. (2017). Metabolic zonation of the liver: the oxygen gradient revisited. Redox Biol. 11: 622–630, https://doi.org/10.1016/j.redox.2017.01.012.Search in Google Scholar PubMed PubMed Central
Kitaoka, S., Hatogai, J., Ochiai, W., and Sugiyama, K. (2018). Zonation of the drug-metabolizing enzyme cytochrome P450 3A in infant mice begins in pre-weaning period. J. Toxicol. Sci. 43: 223–227, https://doi.org/10.2131/jts.43.223.Search in Google Scholar PubMed
Ma, Q. (2013). Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53: 401–426, https://doi.org/10.1146/annurev-pharmtox-011112-140320.Search in Google Scholar PubMed PubMed Central
Martignoni, M., Groothuis, G.M., and de Kanter, R. (2006). Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expet Opin. Drug Metabol. Toxicol. 2: 875–894, https://doi.org/10.1517/17425255.2.6.875.Search in Google Scholar PubMed
O’Sullivan, D., Brosnan, J.T., and Brosnan, M.E. (1998). Hepatic zonation of the catabolism of arginine and ornithine in the perfused rat liver. Biochem. J. 330: 627–632, https://doi.org/10.1042/bj3300627.Search in Google Scholar PubMed PubMed Central
Oinonen, T. and Lindros, K.O. (1998). Zonation of hepatic cytochrome P-450 expression and regulation. Biochem. J. 329: 17–35, https://doi.org/10.1042/bj3290017.Search in Google Scholar PubMed PubMed Central
Paluschinski, M., Jin, C.J., Qvartskhava, N., Görg, B., Wammers, M., Lang, J., Lang, K., Poschmann, G., Stühler, K., and Häussinger, D. (2021). Characterization of the scavenger cell proteome in mouse and rat liver. Biol. Chem. 402: 1073–1085, https://doi.org/10.1515/hsz-2021-0123.Search in Google Scholar PubMed
Patel, R.D., Hollingshead, B.D., Omiecinski, C.J., and Perdew, G.H. (2007). Aryl-hydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver. Hepatology 46: 209–218, https://doi.org/10.1002/hep.21671.Search in Google Scholar PubMed PubMed Central
Rada, P., Rojo, A.I., Offergeld, A., Feng, G.J., Velasco-Martin, J.P., Gonzalez-Sancho, J.M., Valverde, A.M., Dale, T., Regadera, J., and Cuadrado, A. (2015). WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes. Antioxidants Redox Signal. 22: 555–571, https://doi.org/10.1089/ars.2014.6040.Search in Google Scholar PubMed PubMed Central
Rocha, A.S., Vidal, V., Mertz, M., Kendall, T.J., Charlet, A., Okamoto, H., and Schedl, A. (2015). The angiocrine factor respondin3 is a key determinant of liver zonation. Cell Rep. 13: 1757–1764, https://doi.org/10.1016/j.celrep.2015.10.049.Search in Google Scholar PubMed
Schulthess, P., Loffler, A., Vetter, S., Kreft, L., Schwarz, M., Braeuning, A., and Bluthgen, N. (2015). Signal integration by the CYP1A1 promoter--a quantitative study. Nucleic Acids Res. 43: 5318–5330, https://doi.org/10.1093/nar/gkv423.Search in Google Scholar PubMed PubMed Central
Sekine, S., Lan, B.Y., Bedolli, M., Feng, S., and Hebrok, M. (2006). Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice. Hepatology 43: 817–825, https://doi.org/10.1002/hep.21131.Search in Google Scholar PubMed
Tachikawa, M., Sumiyoshiya, Y., Saigusa, D., Sasaki, K., Watanabe, M., Uchida, Y., and Terasaki, T. (2018). Liver zonation index of drug transporter and metabolizing enzyme protein expressions in mouse liver acinus. Drug Metabol. Dispos. 46: 610–618, https://doi.org/10.1124/dmd.117.079244.Search in Google Scholar PubMed
Takiguchi, M. and Mori, M. (1995). Transcriptional regulation of genes for ornithine cycle enzymes. Biochem. J. 312: 649–659, https://doi.org/10.1042/bj3120649.Search in Google Scholar PubMed PubMed Central
Treindl, F., Ruprecht, B., Beiter, Y., Schultz, S., Dottinger, A., Stabeler, A., Joos, T.O., Kling, S., Poetz, O., Fehm, T., et al.. (2016). A bead-based western for high-throughput cellular signal transduction analyses. Nat. Commun. 7: 12852, https://doi.org/10.1038/ncomms12852.Search in Google Scholar PubMed PubMed Central
Treindl, F., Zabinsky, E., Kling, S., Schwarz, M., Braeuning, A., and Templin, M.F. (2020). Array-based Western-blotting reveals spatial differences in hepatic signaling and metabolism following CAR activation. Arch. Toxicol. 94: 1265–1278, https://doi.org/10.1007/s00204-020-02680-y.Search in Google Scholar PubMed
Wegler, C., Gaugaz, F.Z., Andersson, T.B., Wisniewski, J.R., Busch, D., Groer, C., Oslwald, S., Noren, A., Weiss, F., Hammer, H.S., et al.. (2017). Variability in mass spectrometry-based quantification of clinically relevant drug transporters and drug metabolizing enzymes. Mol. Pharm. 14: 3142–3151, https://doi.org/10.1021/acs.molpharmaceut.7b00364.Search in Google Scholar PubMed
Weiss, F., Hammer, H.S., Klein, K., Planatscher, H., Zanger, U.M., Noren, A., Wegler, C., Artursson, P., Joos, T.O., and Poetz, O. (2018). Direct quantification of cytochromes p450 and drug transporters - a rapid, targeted mass spectrometry-based immunoassay panel for tissues and cell culture lysates. Drug Metab. Dispos. 46: 387–396, https://doi.org/10.1124/dmd.117.078626.Search in Google Scholar PubMed
Weiss, F., Schnabel, A., Planatscher, H., van den berg, B.H.J., Serschnitzki, B., Nuessler, A.K., Thasler, W.E., Weiss, T.S., Reuss, M., Stoll, D., et al.. (2015). Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometry. Sci. Rep. 5: 8759, https://doi.org/10.1038/srep08759.Search in Google Scholar PubMed PubMed Central
Yanagimoto, T., Itoh, S., Sawada, M., and Kamataki, T. (1997). Mouse cytochrome P450 (Cyp3a11): predominant expression in liver and capacity to activate aflatoxin B1. Arch. Biochem. Biophys. 340: 215–218, https://doi.org/10.1006/abbi.1997.9900.Search in Google Scholar PubMed
Supplementary Material
The online version of this article offers supplementary material (https://doi.org/10.1515/hsz-2021-0314).
© 2021 Walter de Gruyter GmbH, Berlin/Boston
